Last reviewed · How we verify
Hormone Harmony (DHEA)
At a glance
| Generic name | DHEA |
|---|---|
| Also known as | dehydroepiandrosterone, Prasterone, Dehydroepiandrosterone, Dehydroepiandrosterone, dehydroepiandrosterone; prasterone, Prasterone, Dehydroepiandrosterone, Vaginorm |
| Sponsor | Pro Weight Loss Inc. |
| Drug class | Gonadotropin [EPC] |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
- Hormone imbalance symptoms
Common side effects
Key clinical trials
- Investigating Novel Interventions for Low Back Pain in US Military Veterans: A Randomized Controlled Adaptive Phase II Trial (PHASE2)
- Stress Reduction Program for Iraqi Medical Students (NA)
- Allostatic Load Assessment Using Hair Cortisol and Dehydroepiandrosterone Sulfate Concentration in Patients Affected by Periodontal Disease (NA)
- Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA ) (PHASE2)
- Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment (PHASE3)
- Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer (PHASE2)
- Neurobiological Mechanisms of Stress in Youth With Chronic Widespread Pain (NA)
- Evaluation of Emotion-related Salivary Molecular Biomarkers
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Hormone Harmony CI brief — competitive landscape report
- Hormone Harmony updates RSS · CI watch RSS
- Pro Weight Loss Inc. portfolio CI